Ultrasound probe held by a clinicianIllustration of the liver inside the human body

Original publication: Sterling RK, Lissen E, Clumeck N, et al., Hepatology, 2006

FIB-4 (Fibrosis-4 index)

Is my liver damaged?

Using your age and three blood test results (AST, ALT, platelets), in under a minute, this tool estimates your risk of advanced liver fibrosis using the FIB-4 score. It is intended for adults with a recent blood panel; the score is less reliable under 35 and over 65. The result distinguishes three zones: low risk, an indeterminate zone, or high risk of advanced liver fibrosis.

If you have a fatty liver or risk factors such as excess weight, type 2 diabetes or alcohol use, estimate the risk that your liver has developed fibrosis, using the results of a simple blood test.

4 pieces of information · under 1 minute · Free, no sign-up

Not sure whether you have a fatty liver? Start with the FLI test.

Please read before you start: this guidance tool does not replace a medical consultation. It does not provide a diagnosis.

  • A low or normal result does not rule out the need to see a doctor if you have another symptom that this specific test does not cover.
  • Depending on your age or the guidelines in your country, a consultation may still be advisable even with a negative result.

Ready to start?

4 pieces of information, under 1 minute.

⚠️ A recent blood panel (platelet count, AST, ALT) is needed to complete this test.

Before you start

Who is it for?

Adults with a recent blood panel; score less reliable under 35 and over 65.

What you'll need

your age and three blood test results (AST, ALT, platelets).

What you'll get

a risk level for advanced liver fibrosis.

How to read your result

The result distinguishes three zones: low risk, an indeterminate zone, high risk. In the indeterminate zone or at high risk, a further test (elastography/FibroScan or a specialized blood test) can clarify the state of your liver.

🔒 No signup, no data stored✓ Content based on medical studies

You might also be interested in

Liver fibrosis in a few words

Read the article ▾

What is fatty liver disease (hepatic steatosis)?

Hepatic steatosis, sometimes called "fatty liver disease", is an excessive buildup of fat in liver cells. It is now strongly associated with metabolic syndrome: overweight or obesity, type 2 diabetes, high blood pressure and abnormal blood lipids are very often found together in affected people. Editorially, steatosis is more of a marker and consequence of this metabolic syndrome than an independent, causal cardiovascular risk factor the way smoking or diabetes are.

Why it is often silent

Hepatic steatosis usually causes no symptoms at an early stage. It is most often discovered incidentally, during a routine blood test showing slightly elevated liver enzymes (AST, ALT), or an abdominal ultrasound done for another reason. It is precisely because it is silent that a simple screening tool like the FIB-4 is useful: identifying early on who would benefit from further testing.

What is fibrosis, and why early detection matters

Over time, the inflammation associated with fat buildup can lead to fibrosis: a progressive buildup of scar tissue in the liver. At an advanced stage, fibrosis can progress to cirrhosis and its complications. The FIB-4 score, used in the tool above, is an initial screening test for this advanced fibrosis: a low result has a strong negative predictive value (it reliably rules out advanced fibrosis), while a high or indeterminate result warrants further testing (Fibroscan, Fibrotest, or another specialized test) with a doctor.

The limits of this score

The FIB-4 is meant for initial screening, not for monitoring a liver disease that has already been diagnosed and is being managed: if a diagnosis has already been made by a doctor, this test provides no additional information, hence the filtering question asked before starting. Its reliability is also lower under age 35 and past age 65; beyond that upper threshold, age becomes a major confounding factor in the calculation — which is why the low threshold is raised starting at age 65 to partly compensate for this bias.

Frequently asked questions

What is the FIB-4 score?

The FIB-4 (Fibrosis-4 index) is an initial screening score, calculated from age and 3 blood test results (AST, ALT, platelets), that estimates the probability of advanced liver fibrosis. It is a guidance tool, not a diagnostic tool.

Why does this test require a blood panel?

Unlike most tools on this site, the FIB-4 is not a simple self-reported questionnaire: it is calculated from blood test results (AST, ALT, platelets), like the general cardiovascular risk score. You therefore need these values on hand, from a recent blood draw.

Does this test apply if I already have a liver disease diagnosis?

No. The FIB-4 score is meant for initial screening of liver fibrosis, not for monitoring an already-diagnosed liver disease. If you already have a diagnosis, continue the follow-up already in place with your doctor or hepatologist.

Sources

  • Sterling RK, Lissen E, Clumeck N, et al. "Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection." Hepatology. 2006;43(6):1317-1325.

Content last updated: September 21, 2026.

Content based on medical studies.

Reviewed by Dr BARTHELEMY Pierre L., general practitioner

What else would you like to check today?

My cardiovascular prevention profile

Free check-up, no sign-up

A short questionnaire, then the tests that are useful for you, and a results page to show your doctor.

Start my profile →
A doctor explaining a document to a patient during a consultation.

Learn and understand

Hygietest Blog

All articles

58 articles sorted by topic, written from medical guidelines.

Why Hygietest?

Hygietest is a health hub dedicated to primary care, centered on prevention. The idea is simple: bring together, in one place, several screening tools accessible to everyone, to help each person better understand their health even before seeing a doctor.

Multiple tools, focused on prevention

The site is gradually offering several screening tools, covering prevention in general and cardiovascular health in particular — two areas where catching an early signal often changes what comes next: sleep, blood pressure, weight, chronic fatigue. Each tool is designed for one-off use, with no account and no tracking over time.

Simple tools, built on serious foundations

Each questionnaire is based on studies from the medical literature — both established and recent — already used in clinical practice. Hygietest's job is to make them accessible: the same method, the same rigor, but language designed to be understood without any medical training.

Free, with no personal data collection

Hygietest is entirely free. No identity is requested, no payment details, no account creation. Calculations happen directly in your browser: nothing is transmitted, nothing is stored.

What Hygietest is not

Hygietest does not replace, and is not intended to replace, a medical consultation — whether as part of a screening approach or when symptoms appear. A reassuring result never rules out the possibility of seeing a doctor: if doubt remains, or if a symptom not covered by the test worries you, talking to a healthcare professional remains the right approach.

Screening is not diagnosing

This is an important distinction, often misunderstood: a screening tool doesn't serve the same purpose as a diagnostic test. Its main value lies in its ability to flag a risk — its sensitivity — rather than to confirm a diagnosis with certainty, which is the role of specificity and further testing carried out by a doctor. A positive result on a screening test is therefore not a diagnosis: it's an indication that it's worth discussing with a healthcare professional, who will decide whether further tests are needed.

Our goal

Hygietest is purely a tool for making screening more accessible, designed as a complement — never a substitute — to the usual care pathway. The ultimate goal is simple: promote screening to support prevention, by increasing the likelihood that people take the step of seeing a doctor when it's useful to do so.

Frequently asked questions
Is Hygietest free?

Yes. Every test is free, with no sign-up required.

Who is behind Hygietest?

The site is offered and reviewed by Dr. BARTHELEMY Pierre L., a general practitioner. The tests weren't invented for the site: they are scores published in medical journals and recommended by health authorities.

Are the tests reliable?

Each tool reuses the questions, formulas, and thresholds from the original publication. Sources are cited on every page. Like any screening test, they estimate a risk: they don't confirm or rule out a disease.

Can a test replace a medical consultation?

No. A low result doesn't rule out seeing a doctor if a symptom worries you, and a high result is a reason to discuss it with your doctor. In an emergency, call your local emergency number.

What happens to my answers?

Nothing: calculations happen in your browser. No answer is transmitted to or stored by Hygietest. The site measures its audience anonymously and in aggregate (page views, country, device type), without cookies, via Vercel; your test answers are never included.

Which tests are offered?

Fourteen tests: cardiovascular risk (SCORE2), cardiovascular risk with diabetes (SCORE2-Diabetes), high blood pressure (home blood pressure monitoring), diabetes risk (FINDRISC), overweight and obesity (BMI), fatty liver disease (FLI), liver fibrosis (FIB-4), sleep apnea (STOP-BANG), sleepiness (Epworth Sleepiness Scale), nicotine dependence (Fagerström test), alcohol consumption (AUDIT-C), physical activity (IPAQ/GPAQ), burnout (CBI), and depression (PHQ-9).

Which test should I start with?

If you don't have a specific question in mind, start with cardiovascular risk and blood pressure: the two most useful markers in prevention.

A doctor talking with a patient during a consultation.